Karin Potthoff

3.8k total citations · 1 hit paper
60 papers, 2.3k citations indexed

About

Karin Potthoff is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Karin Potthoff has authored 60 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 26 papers in Pulmonary and Respiratory Medicine and 10 papers in Hematology. Recurrent topics in Karin Potthoff's work include Cancer Treatment and Pharmacology (12 papers), Cancer survivorship and care (10 papers) and Advanced Breast Cancer Therapies (8 papers). Karin Potthoff is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Cancer survivorship and care (10 papers) and Advanced Breast Cancer Therapies (8 papers). Karin Potthoff collaborates with scholars based in Germany, United States and Switzerland. Karin Potthoff's co-authors include Martin Krönke, Stefan Schütze, Katja Wiegmann, Thomas Machleidt, Dinko Berkovic, Hartmut Bertz, Jürgen Finke, Karen Steindorf, Joachim Wiskemann and Martina E. Schmidt and has published in prestigious journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Karin Potthoff

52 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced “Acidic” sphingomyelin breakdown

1992 949 citations Karin Potthoff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin Potthoff Germany	20	828	804	419	397	327	60	2.3k
Dimitrios C. Ziogas Greece	26	755 0.9×	913 1.1×	482 1.2×	301 0.8×	188 0.6×	99	2.2k
Yoshihiro Fujimori Japan	22	1.1k 1.3×	429 0.5×	593 1.4×	805 2.0×	287 0.9×	99	3.1k
Michael Schuster United States	27	1.6k 2.0×	676 0.8×	871 2.1×	253 0.6×	226 0.7×	76	3.0k
Dan Grisaru Israel	29	736 0.9×	419 0.5×	285 0.7×	225 0.6×	131 0.4×	125	2.9k
Marieke J. H. Coenen Netherlands	34	1.1k 1.3×	369 0.5×	217 0.5×	844 2.1×	133 0.4×	131	3.2k
Csaba Szalai Hungary	27	640 0.8×	499 0.6×	120 0.3×	780 2.0×	337 1.0×	93	2.3k
Terzah M. Horton United States	33	2.3k 2.8×	701 0.9×	655 1.6×	396 1.0×	329 1.0×	108	3.7k
Mitchell J. Machiela United States	21	1.1k 1.3×	324 0.4×	144 0.3×	311 0.8×	229 0.7×	68	2.7k
Claudio Favre Italy	27	490 0.6×	409 0.5×	489 1.2×	303 0.8×	90 0.3×	94	2.0k
Anastasios E. Germenis Greece	30	469 0.6×	308 0.4×	243 0.6×	728 1.8×	390 1.2×	127	2.7k

Countries citing papers authored by Karin Potthoff

Since Specialization

Citations

This map shows the geographic impact of Karin Potthoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Potthoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Potthoff more than expected).

Fields of papers citing papers by Karin Potthoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Potthoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Potthoff. The network helps show where Karin Potthoff may publish in the future.

Co-authorship network of co-authors of Karin Potthoff

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Potthoff. A scholar is included among the top collaborators of Karin Potthoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Potthoff. Karin Potthoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Potthoff, Karin, Norbert Marschner, Lothar Müller, et al.. (2025). Final Results of ERBIMOX: A Randomized Phase II Study of Modified FOLFOX7 With or Without Cetuximab as First-Line Treatment for KRAS Wild-type Metastatic Colorectal Cancer. Journal of Gastrointestinal Cancer. 56(1). 141–141.

Marschner, Norbert, T Seufferlein, Karin Potthoff, et al.. (2024). Changes in survival of >3800 patients with metastatic colorectal cancer in Germany: results from a 16-year prospective longitudinal real-world data analysis. SHILAP Revista de lepidopterología. 4. 100040–100040. 1 indexed citations

Dechow, Tobias, Jorge Riera‐Knorrenschild, Björn Hackanson, et al.. (2023). First‐linenab‐paclitaxel plus carboplatin for patients with advanced non‐small cell lung cancer: Final results of the NEPTUN study. International Journal of Cancer. 153(1). 141–152. 2 indexed citations

Jakob, Andreas, Arnd Nusch, Roland Schnell, et al.. (2022). Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study. Journal of bone oncology. 33. 100420–100420. 7 indexed citations

Metz, Michael, Thomas Fietz, Stefan Zacharias, et al.. (2021). Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients. Supportive Care in Cancer. 29(11). 6633–6643. 5 indexed citations

Decker, Thomas, Ulrike Söling, Antje Hahn, et al.. (2020). Final results from IMPROVE: a randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients’ preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer. BMC Cancer. 20(1). 286–286. 4 indexed citations

Uhlig, Johannes, P. Stübs, Lutz Müller, et al.. (2020). 457P 1st-line panitumumab plus FOLFIRI or FOLFOX for patients with RAS wildtype metastatic colorectal cancer in Germany: Interim results of the non-interventional study VALIDATE. Annals of Oncology. 31. S436–S436. 1 indexed citations

Marschner, Norbert, Christoph Salat, Ulrike Söling, et al.. (2018). Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel. Clinical Breast Cancer. 18(6). e1323–e1337. 12 indexed citations

Schmidt, Martina E., Joachim Wiskemann, Jan Oelmann, et al.. (2015). Resistance Exercise and Inflammation in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy: Mediation Analysis From a Randomized, Controlled Intervention Trial. International Journal of Radiation Oncology*Biology*Physics. 94(2). 329–337. 73 indexed citations

10.

Potthoff, Karin, Gregor Habl, Thomas Brückner, et al.. (2014). Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial. BMC Cancer. 14(1). 270–270. 2 indexed citations

11.

Steindorf, Karen, Martina E. Schmidt, Oliver Klassen, et al.. (2014). Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life. Annals of Oncology. 25(11). 2237–2243. 163 indexed citations

12.

Potthoff, Karin, Martina E. Schmidt, Joachim Wiskemann, et al.. (2013). Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study. BMC Cancer. 13(1). 162–162. 51 indexed citations

13.

Hasselblatt, Peter, Karin Potthoff, Hartmut Bertz, et al.. (2012). Remission of refractory C rohn's disease by high‐dose cyclophosphamide and autologous peripheral blood stem cell transplantation. Alimentary Pharmacology & Therapeutics. 36(8). 725–735. 45 indexed citations

14.

Jensen, Alexandra D, Jürgen Krauß, Karin Potthoff, et al.. (2012). Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial. Radiation Oncology. 7(1). 57–57. 5 indexed citations

15.

Potthoff, Karin, Ralf‐Dieter Hofheinz, Jessica C. Hassel, et al.. (2010). Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion. Annals of Oncology. 22(3). 524–535. 86 indexed citations

16.

Habl, Gregor, Alexandra D Jensen, Karin Potthoff, et al.. (2010). Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol. BMC Cancer. 10(1). 651–651. 7 indexed citations

17.

Kreisel, Wolfgang, Karin Potthoff, Hartmut Bertz, et al.. (2003). Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation. Bone Marrow Transplantation. 32(3). 337–340. 58 indexed citations

18.

Cl, Berger, Hartmut Bertz, Claudia Schmoor, et al.. (1999). Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors. Bone Marrow Transplantation. 23(10). 983–990. 29 indexed citations

19.

Bertz, Hartmut, Karin Potthoff, Roland Mertelsmann, & Jürgen Finke. (1997). Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity. Bone Marrow Transplantation. 19(12). 1169–1173. 25 indexed citations

20.

Potthoff, Karin, et al.. (1979). [Spontaneous secretion of growth hormone in children with constitutional delay of growth and adolescence and with early normal puberty (author's transl)].. PubMed. 127(9). 561–5. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact